Our finalists for this year’s $200K Challenge are experiencing our traditional event in a very unique way. The event will be held virtually, with the PitchOff taking place on September 17th and the Award Celebration on October 1st, and will be completely free with registration. While this year’s event looks different, we still want to bring attention to each of our unique finalists and their innovations.
Continue readingThe summer of 2020 continues to bring forth exciting news on our resident companies. LaunchPad Medical has announced that it received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient pilot clinical study. The goal is to examine the safety and efficacy of Tetranite®, the company’s bone adhesive biomaterial, to immediately stabilize dental implants following tooth extractions.
Continue reading
Though this year’s $200K Challenge will take place virtually, this year’s finalists’ are still top of mind. The PitchOff will now be held on Zoom on September 17th from 5-8pm, as will the Award Celebration on October 1st at 5pm. Additionally, the $200K Challenge will be free with registration.
Recently, we caught up with Michael House, President of Cx Therapeutics. His titles include Principal Investigator, Mother Infant Research Institute and Associate Professor of Medicine at Tufts Medical Center.
Continue reading
In April of 2019, Newburyport, Massachusetts-based EnClear Therapies was named a winner in the 8th annual M2D2 $200K Challenge. Their innovation: a treatment device to stop progress of neurodegenerative diseases. The 2020 Challenge is coming up this fall, and because we’re always interested in the progress of past winners, we reached out to EnClear’s Vice President of R&D/Operations Kevin Kalish to get an update.
Continue readingAlthough this year’s challenge will occur virtually, we want to keep the spotlight on this year’s Finalists. The PitchOff will now take place on September 17th from 5-8pm, with the Award Ceremony happening on October 1st at 5pm. Registration for the $200k Challenge will be free.
Profilagen is a start-up preclinical LLC bringing forward a technology to regenerate damaged cardiac muscle. We spoke with CEO Claudine Bruck about the inspiration behind Profilagen, and their story so far.
Continue reading
On June 11, M2D2 Resident Company Glyscend Therapeutics announced the closing of a Series A financing round valued at $20.5 million. Glyscend will use this funding to further support the development of its novel oral polymer therapy for patients with type 2 diabetes, as well as other metabolic diseases.
Continue readingDuring the second week of June, two M2D2 resident companies took part in this year’s BIO Digital Convention. LivOnyx Inc. and Versatope Therapeutics both presented their progress and innovative solutions during BIO Digital Week, a virtual convention featuring interactive sessions covering therapeutics, digital health, patient advocacy, and more. Both of these startups are working on solutions that are very relevant during the COVID-19 pandemic.
Continue reading
M2D2 Resident Company Versatope and Netherlands-based Intravacc announced on June 8th, that they have signed a research service agreement to further develop a universal vaccine against influenza. The vaccine will be based on Intravacc’s innovative Outer Membrane Vesicles (OMV) technology, which is proven to be safe in humans.
Continue readingWe are always excited to share the news about our resident companies’ successes. Tuesday morning, LaunchPad Medical announced that they received support up to $1.8 million from the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center. It was funded by the National Institute of Dental and Cranial Research to improve the translation of promising tissue engineering and regenerative medicine technologies for dental, oral, and craniofacial clinical practice.
Continue reading
Our 15 finalists for the 2020 $200K Challenge have innovative, lifesaving ideas. This year’s challenge will take pace virtually on Zoom. The PitchOff will now happen on September 17th from 5-8pm with the Awards Ceremony taking pace on October 1st at 5pm. The $200K Challenge will be free with registration.
$200K Challenge Finalist CranioSense is developing IPASS, a medical device for noninvasive assessment of intracranial pressure (ICP), a critical parameter in traumatic brain injury (TBI) and other medical conditions affecting the brain. We talked with CEO Gordon Hirschman about what brought them to their innovation and the 2020 $200K Challenge.
Continue reading